Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

Top 10 Oil-producing Countries (Updated 2024)

11 Canadian Crypto ETFs (Updated 2024)

Can You Invest in Elon Musk’s Neuralink? (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

7 Biggest Lithium-mining Companies in 2024

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Top 10 Copper-producing Companies (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies in 2024

Trending Press Releases

WESTERN COPPER AND GOLD STRENGTHENS MANAGEMENT TEAM

Labyrinth Resources Limited (ASX: LRL) – Trading Halt

New High-Grade Gold Discovery at Golden Ridge, NE Tasmania. ​Grades up to 99.4g/t Au Recorded

AU$1.50 Valuation for Siren Gold ‘Achievable,’ says Analyst Report

Option to Acquire Residual 49% of Comet Vale and Acquisition of Vivien Gold Project

Ramp Metals Announces $4.5M Non-Brokered Private Placement Led by Strategic Investor Eric Sprott

More Press Releases
Trending Companies

Ora Gold Limited

OAU:AU

Alvopetro Energy

ALV:CC

Western Copper and Gold

WRN:CA

Purpose Bitcoin ETF

BTCC:CA
More Companies
Trending Reports

2024 Gold Outlook Report

2024 Lithium Market Outlook (Updated for Q2)

Silver Price Forecast - What Happened And Where Do We Go From Here?

2024 Uranium Outlook (Updated for Q2)

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
Radiopharm Theranostics

Radiopharm Theranostics

ASX:RAD
Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer.
CEO Interviews
Press Releases

Radiopharm Theranostics Receives FDA IND Approval for Phase 2b Imaging Trial in Brain Metastases

First Patient Dosed with PD-L1 Nanobody in Phase 1 Therapeutic Non-Small Cell Lung Cancer Trial

Investor Webinar – 3pm AEST Tuesday 2 July

INNspired
Radiopharm Theranostics
Sign up to get your FREE

Radiopharm Theranostics Investor Kit

and hear about exciting investment opportunities.
  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

*Disclaimer: This profile is sponsored by Radiopharm Theranostics ( ASX:RAD ). This profile provides information which was sourced by the Investing News Network (INN) and approved by Radiopharm Theranostics in order to help investors learn more about the company. Radiopharm Theranostics is a client of INN. The company's campaign fees pay for INN to create and update this profile.

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with Radiopharm Theranostics and seek advice from a qualified investment advisor.

The Conversation (0)
Radiopharm Theranostics
Sign up to get your FREE

Radiopharm Theranostics Investor Kit

and hear about exciting investment opportunities.
  • Corporate info
  • Insights
  • Growth strategies
  • Upcoming projects

GET YOUR FREE INVESTOR KIT

Interactive Chart

×
}); window.REBELMOUSE_ACTIVE_TASKS_QUEUE.push(function(){ window.REBELMOUSE_STDLIB.loadExternalScript("https://cdn.wishpond.net/connect.js?merchantId=1573265&writeKey=4cdff20f7c2c", function() { }); }); window.REBELMOUSE_ACTIVE_TASKS_QUEUE.push(function(){ window.REBELMOUSE_STDLIB.loadExternalScript("https://929407712b26442d83ac75ef15c959df.js.ubembed.com", function() { }); }); window.REBELMOUSE_ACTIVE_TASKS_QUEUE.push(function(){ const urlParams = new URLSearchParams(window.location.search); const token = urlParams.get('dtd'); const id = urlParams.get('id'); if(token && id){ let date = new Date(); date.setTime(date.getTime() + (365*24*60*60*1000)); document.cookie = `cb_token=${JSON.parse(localStorage.getItem('user')).cb_token}; expires=${date.toUTCString()}; path=/`; document.cookie = `sessionid=${JSON.parse(localStorage.getItem('user')).cb_token}; expires=${date.toUTCString()}; path=/my-inn`; document.cookie = `user_logged_in=1; expires=${date.toUTCString()}; path=/my-inn`; document.cookie = `sessionid=${JSON.parse(localStorage.getItem('user')).cb_token}; expires=${date.toUTCString()}; path=/free-report-online`; document.cookie = `user_logged_in=1; expires=${date.toUTCString()}; path=/free-report-online`; fetch('https://investingnews.com/r/kappa/api/v2/reader/clear_sessionid') fetch('https://investingnews.com/r/kappa/api/v2/reader/clear_logged_in') } });